Peoria, ILNCT06721013Now EnrollingIRB Ready

Immune Thrombocytopenia Clinical Trial in Peoria, IL

Access cutting-edge immune thrombocytopenia treatment through this clinical trial at a research site in Peoria. Study-provided care at no cost to qualified participants.

Sponsored by Eli Lilly and Company

Quick Self-Assessment

See if you qualify for this Peoria location

Preparing your pre-screening questions...

Expert Care in Peoria

Access immune thrombocytopenia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related immune thrombocytopenia treatment provided free

Apply for This Peoria Location

Check if you qualify for this immune thrombocytopenia clinical trial in Peoria, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Peoria

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Peoria site if eligible
  4. 4Begin participation

About This Immune Thrombocytopenia Study in Peoria

The purpose of the phase 1 part of this study is to evaluate how well pirtobrutinib is tolerated and what side effects may occur. The phase 2 part of the study will further investigate efficacy and safety of multiple pirtobrutinib dosages versus placebo. The study drug will be administered orally in participants with Primary Immune Thrombocytopenia (ITP). Blood tests will be performed to check how much pirtobrutinib gets into the bloodstream and how long it takes the body to eliminate it. The

Sponsor: Eli Lilly and Company

Who Can Participate

Inclusion Criteria

Have a diagnosis of primary ITP, defined as isolated thrombocytopenia not associated with another known disease process
Have documented history of response, defined as 2 or more platelet counts greater than or equal to 50,000/microliter (μL), to at least 1 prior line of therapy. Splenectomy is considered a line of therapy
Have relapsed or treatment-resistant primary ITP, with no available therapies known to provide clinical benefit
Have a platelet count less than 30,000/μL on 2 occasions more than 5 days apart in the 15 days before randomization
Have adequate liver, renal, and hematologic functions as defined by a table
Are willing to follow contraception requirements

Exclusion Criteria

Have a history of any thrombotic or embolic event within 12 months before screening
Had a transfusion with blood or blood products or plasmapheresis within 14 days (Phase 1) or within 28 days (Phase 2) of randomization
Have significant cardiovascular disease

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Peoria?

Yes, this clinical trial (NCT06721013) has an active research site in Peoria, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Immune Thrombocytopenia Treatment Options in Peoria, IL

If you're searching for immune thrombocytopenia treatment options in Peoria, IL, this clinical trial (NCT06721013) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Peoria research site is actively enrolling participants for this clinical trial. You'll receive care from experienced immune thrombocytopenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all immune thrombocytopenia clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Peoria, IL

See all multiple myeloma clinical trials recruiting in Peoria — not just this study.

Browse Multiple Myeloma Trials in Peoria

Ready to Join in Peoria?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Peoria, IL